Payload-defined target

The term "Payload-defined target" does not refer to a specific biological molecule, receptor, or enzyme. Instead, it is a descriptive or placeholder phrase often used in the context of targeted delivery systems, such as antibody-drug conjugates (ADCs), to indicate that the therapeutic effect is driven by the specific cytotoxic or functional payload being delivered rather than a single predefined biological receptor. In such systems, the target of the delivery vehicle (e.g., a cell-surface antigen) is distinct from the target of the payload (e.g., microtubules, DNA, or topoisomerase). Because this term represents a functional category or a methodological description rather than a distinct molecular entity, it cannot be classified within standard biological or pharmacological frameworks. Consequently, it lacks specific biological functions, disease roles, or interacting drugs associated with a unique protein or gene.

Not applicable as this is not a specific molecular target.